IBRXImmunityBio, Inc.Mar 3, 2026Q4 2025
Read transcript →ImmunityBio, Inc. (IBRX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$7.07
+5.21%
Mkt Cap $7.59B
IBRXImmunityBio, Inc.Mar 3, 2026IBRXImmunityBio, Inc.Mar 3, 2026NASDAQ·Healthcare·Biotechnology
$7.07
+5.21%
Mkt Cap $7.59B
IBRXImmunityBio, Inc.Mar 3, 2026Q4 2025
Read transcript →